BANK OF AMERICA CORP /DE/ - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 273 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$19,192,727
-5.1%
502,559
+2.2%
0.00%0.0%
Q2 2023$20,224,237
-46.8%
491,715
-25.8%
0.00%
-50.0%
Q1 2023$38,019,772
+28.5%
662,250
+25.5%
0.00%
+33.3%
Q4 2022$29,598,399
+32.9%
527,883
+0.4%
0.00%0.0%
Q3 2022$22,276,000
-22.7%
525,911
-1.4%
0.00%0.0%
Q2 2022$28,809,000
-5.4%
533,193
+12.6%
0.00%0.0%
Q1 2022$30,439,000
+3.1%
473,696
+7.5%
0.00%0.0%
Q4 2021$29,527,000
+5.5%
440,766
+7.8%
0.00%0.0%
Q3 2021$27,989,000
+26.0%
408,730
+25.6%
0.00%
+50.0%
Q2 2021$22,208,000
-3.0%
325,456
-1.8%
0.00%
-33.3%
Q1 2021$22,906,000
+11.4%
331,528
+4.7%
0.00%0.0%
Q4 2020$20,557,000
+21.5%
316,660
-11.6%
0.00%
+50.0%
Q3 2020$16,922,000
-5.2%
358,370
-5.6%
0.00%
-33.3%
Q2 2020$17,846,000
+45.4%
379,782
+38.2%
0.00%
+50.0%
Q1 2020$12,273,000
-8.1%
274,733
+20.0%
0.00%0.0%
Q4 2019$13,348,000
-7.2%
229,030
-4.4%
0.00%0.0%
Q3 2019$14,390,000
+15.3%
239,569
+7.2%
0.00%0.0%
Q2 2019$12,481,000
-19.7%
223,468
-19.9%
0.00%0.0%
Q1 2019$15,543,000
+89.4%
278,933
+53.3%
0.00%
+100.0%
Q4 2018$8,207,000
-53.1%
181,985
-31.5%
0.00%
-66.7%
Q3 2018$17,493,000
-15.0%
265,587
-16.9%
0.00%0.0%
Q2 2018$20,584,000
-0.1%
319,588
-14.1%
0.00%
-25.0%
Q1 2018$20,599,000
-20.2%
372,229
-31.0%
0.00%0.0%
Q4 2017$25,804,000
-15.3%
539,162
-10.7%
0.00%
-20.0%
Q3 2017$30,479,000
+30.7%
603,805
+41.2%
0.01%0.0%
Q2 2017$23,316,000
+6.6%
427,750
-17.6%
0.01%
+25.0%
Q1 2017$21,873,000
+53.9%
519,198
+213.4%
0.00%
+33.3%
Q4 2016$14,214,000
+22.7%
165,680
+18.1%
0.00%0.0%
Q3 2016$11,585,000
+88.9%
140,330
+82.6%
0.00%
+200.0%
Q2 2016$6,132,000
+27.0%
76,859
+7.2%
0.00%0.0%
Q1 2016$4,830,000
-34.6%
71,707
-34.2%
0.00%
-50.0%
Q4 2015$7,385,000
+6.0%
108,974
-6.9%
0.00%0.0%
Q3 2015$6,969,000
+169.0%
117,040
+204.3%
0.00%
+100.0%
Q2 2015$2,591,000
+546.1%
38,457
+492.0%
0.00%
Q1 2015$401,000
-50.7%
6,496
-56.6%
0.00%
Q4 2014$813,000
+236.0%
14,982
+205.9%
0.00%
Q3 2014$242,000
+2.5%
4,897
-2.3%
0.00%
Q2 2014$236,000
-73.0%
5,014
-73.6%
0.00%
Q1 2014$874,000
-27.5%
19,005
-24.9%
0.00%
Q4 2013$1,206,000
+33.4%
25,294
+12.6%
0.00%
Q3 2013$904,000
-40.4%
22,454
-45.8%
0.00%
-100.0%
Q2 2013$1,518,00041,4540.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q1 2022
NameSharesValueWeighting ↓
VeriStar Capital Management LP 268,000$10,234,9208.72%
Madison Avenue Partners, LP 964,667$36,840,6335.23%
Pavadi Capital LLC 99,999$3,818,9624.97%
KESTREL INVESTMENT MANAGEMENT CORP 122,450$4,6762.96%
Sapience Investments, LLC 245,700$9,383,2832.26%
Ellsworth Advisors, LLC 102,500$3,882,7001.38%
Point72 Europe (London) LLP 464,462$17,737,8041.09%
COOKE & BIELER LP 2,714,194$103,655,0691.01%
TANDEM CAPITAL MANAGEMENT CORP /ADV 75,586$2,886,6300.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,827$43,033,5230.95%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders